Global Opioid Induced Constipation (OIC) Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Opioid Induced Constipation (OIC) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Opioid Induced Constipation (OIC) Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Opioid Induced Constipation (OIC) Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Lubiprostone segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Opioid Induced Constipation (OIC) Drug include Ironwood Pharmaceuticals, Daiichi Sankyo Co, Pfizer, Progenics Pharmaceuticals, and Shionogi &, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Opioid Induced Constipation (OIC) Drug market is split by Type and by Distribution Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Opioid Induced Constipation (OIC) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid Induced Constipation (OIC) Drug, with price, sales, revenue and global market share of Opioid Induced Constipation (OIC) Drug from 2019 to 2022.
Chapter 3, the Opioid Induced Constipation (OIC) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Induced Constipation (OIC) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, distribution channel, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Opioid Induced Constipation (OIC) Drug market forecast, by regions, type and distribution channel, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Opioid Induced Constipation (OIC) Drug.
Chapter 13, 14, and 15, to describe Opioid Induced Constipation (OIC) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Opioid Induced Constipation (OIC) Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Opioid Induced Constipation (OIC) Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Lubiprostone segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Opioid Induced Constipation (OIC) Drug include Ironwood Pharmaceuticals, Daiichi Sankyo Co, Pfizer, Progenics Pharmaceuticals, and Shionogi &, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Opioid Induced Constipation (OIC) Drug market is split by Type and by Distribution Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Other
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Ironwood Pharmaceuticals
- Daiichi Sankyo Co
- Pfizer
- Progenics Pharmaceuticals
- Shionogi &
- Allergan
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma
- Mundipharma International Limited
- Ono Pharmaceutical
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma
- Bausch Health
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Opioid Induced Constipation (OIC) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid Induced Constipation (OIC) Drug, with price, sales, revenue and global market share of Opioid Induced Constipation (OIC) Drug from 2019 to 2022.
Chapter 3, the Opioid Induced Constipation (OIC) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Induced Constipation (OIC) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, distribution channel, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Opioid Induced Constipation (OIC) Drug market forecast, by regions, type and distribution channel, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Opioid Induced Constipation (OIC) Drug.
Chapter 13, 14, and 15, to describe Opioid Induced Constipation (OIC) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Opioid Induced Constipation (OIC) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioid Induced Constipation (OIC) Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Market Analysis by Distribution Channel
1.3.1 Overview: Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Opioid Induced Constipation (OIC) Drug Market Size & Forecast
1.4.1 Global Opioid Induced Constipation (OIC) Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Opioid Induced Constipation (OIC) Drug Sales in Volume (2017-2028)
1.4.3 Global Opioid Induced Constipation (OIC) Drug Price (2017-2028)
1.5 Global Opioid Induced Constipation (OIC) Drug Production Capacity Analysis
1.5.1 Global Opioid Induced Constipation (OIC) Drug Total Production Capacity (2017-2028)
1.5.2 Global Opioid Induced Constipation (OIC) Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioid Induced Constipation (OIC) Drug Market Drivers
1.6.2 Opioid Induced Constipation (OIC) Drug Market Restraints
1.6.3 Opioid Induced Constipation (OIC) Drug Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Ironwood Pharmaceuticals
2.1.1 Ironwood Pharmaceuticals Details
2.1.2 Ironwood Pharmaceuticals Major Business
2.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
2.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Daiichi Sankyo Co
2.2.1 Daiichi Sankyo Co Details
2.2.2 Daiichi Sankyo Co Major Business
2.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product and Services
2.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Product and Services
2.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Progenics Pharmaceuticals
2.4.1 Progenics Pharmaceuticals Details
2.4.2 Progenics Pharmaceuticals Major Business
2.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
2.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Shionogi &
2.5.1 Shionogi & Details
2.5.2 Shionogi & Major Business
2.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Product and Services
2.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Opioid Induced Constipation (OIC) Drug Product and Services
2.6.4 Allergan Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Nektar Therapeutics
2.7.1 Nektar Therapeutics Details
2.7.2 Nektar Therapeutics Major Business
2.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product and Services
2.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Purdue Pharma
2.8.1 Purdue Pharma Details
2.8.2 Purdue Pharma Major Business
2.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product and Services
2.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 S.L.A. Pharma
2.9.1 S.L.A. Pharma Details
2.9.2 S.L.A. Pharma Major Business
2.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product and Services
2.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Mundipharma International Limited
2.10.1 Mundipharma International Limited Details
2.10.2 Mundipharma International Limited Major Business
2.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product and Services
2.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Ono Pharmaceutical
2.11.1 Ono Pharmaceutical Details
2.11.2 Ono Pharmaceutical Major Business
2.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
2.11.4 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Takeda Pharmaceutical Company Limited Details
2.12.2 Takeda Pharmaceutical Company Limited Major Business
2.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product and Services
2.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Theravance Biopharma
2.13.1 Theravance Biopharma Details
2.13.2 Theravance Biopharma Major Business
2.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product and Services
2.13.4 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Bausch Health
2.14.1 Bausch Health Details
2.14.2 Bausch Health Major Business
2.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Product and Services
2.14.4 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Cosmo Pharmaceuticals SA
2.15.1 Cosmo Pharmaceuticals SA Details
2.15.2 Cosmo Pharmaceuticals SA Major Business
2.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product and Services
2.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Daewoong Pharmaceutical
2.16.1 Daewoong Pharmaceutical Details
2.16.2 Daewoong Pharmaceutical Major Business
2.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
2.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 C.B. Fleet Company
2.17.1 C.B. Fleet Company Details
2.17.2 C.B. Fleet Company Major Business
2.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product and Services
2.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Sucampo Pharmaceuticals
2.18.1 Sucampo Pharmaceuticals Details
2.18.2 Sucampo Pharmaceuticals Major Business
2.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
2.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 OPIOID INDUCED CONSTIPATION (OIC) DRUG BREAKDOWN DATA BY MANUFACTURER
3.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Opioid Induced Constipation (OIC) Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Opioid Induced Constipation (OIC) Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Opioid Induced Constipation (OIC) Drug Manufacturer Market Share in 2021
3.5 Global Opioid Induced Constipation (OIC) Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Opioid Induced Constipation (OIC) Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Region
4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2028)
4.2 North America Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
4.3 Europe Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
4.4 Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
4.5 South America Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
4.6 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Type (2017-2028)
5.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2028)
5.3 Global Opioid Induced Constipation (OIC) Drug Price by Type (2017-2028)
6 MARKET SEGMENT BY DISTRIBUTION CHANNEL
6.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Distribution Channel (2017-2028)
6.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2028)
6.3 Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
7.1 North America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
7.2 North America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
7.3 North America Opioid Induced Constipation (OIC) Drug Market Size by Country
7.3.1 North America Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
8.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
8.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
8.3 Europe Opioid Induced Constipation (OIC) Drug Market Size by Country
8.3.1 Europe Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL
9.1 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
9.3 Asia-Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region
9.3.1 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL
10.1 South America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
10.2 South America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
10.3 South America Opioid Induced Constipation (OIC) Drug Market Size by Country
10.3.1 South America Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
11.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
11.3 Middle East & Africa Opioid Induced Constipation (OIC) Drug Market Size by Country
11.3.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Opioid Induced Constipation (OIC) Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Opioid Induced Constipation (OIC) Drug
12.3 Opioid Induced Constipation (OIC) Drug Production Process
12.4 Opioid Induced Constipation (OIC) Drug Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Opioid Induced Constipation (OIC) Drug Typical Distributors
13.3 Opioid Induced Constipation (OIC) Drug Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Opioid Induced Constipation (OIC) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioid Induced Constipation (OIC) Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Market Analysis by Distribution Channel
1.3.1 Overview: Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Opioid Induced Constipation (OIC) Drug Market Size & Forecast
1.4.1 Global Opioid Induced Constipation (OIC) Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Opioid Induced Constipation (OIC) Drug Sales in Volume (2017-2028)
1.4.3 Global Opioid Induced Constipation (OIC) Drug Price (2017-2028)
1.5 Global Opioid Induced Constipation (OIC) Drug Production Capacity Analysis
1.5.1 Global Opioid Induced Constipation (OIC) Drug Total Production Capacity (2017-2028)
1.5.2 Global Opioid Induced Constipation (OIC) Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioid Induced Constipation (OIC) Drug Market Drivers
1.6.2 Opioid Induced Constipation (OIC) Drug Market Restraints
1.6.3 Opioid Induced Constipation (OIC) Drug Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Ironwood Pharmaceuticals
2.1.1 Ironwood Pharmaceuticals Details
2.1.2 Ironwood Pharmaceuticals Major Business
2.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
2.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Daiichi Sankyo Co
2.2.1 Daiichi Sankyo Co Details
2.2.2 Daiichi Sankyo Co Major Business
2.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product and Services
2.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Product and Services
2.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Progenics Pharmaceuticals
2.4.1 Progenics Pharmaceuticals Details
2.4.2 Progenics Pharmaceuticals Major Business
2.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
2.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Shionogi &
2.5.1 Shionogi & Details
2.5.2 Shionogi & Major Business
2.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Product and Services
2.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Opioid Induced Constipation (OIC) Drug Product and Services
2.6.4 Allergan Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Nektar Therapeutics
2.7.1 Nektar Therapeutics Details
2.7.2 Nektar Therapeutics Major Business
2.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product and Services
2.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Purdue Pharma
2.8.1 Purdue Pharma Details
2.8.2 Purdue Pharma Major Business
2.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product and Services
2.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 S.L.A. Pharma
2.9.1 S.L.A. Pharma Details
2.9.2 S.L.A. Pharma Major Business
2.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product and Services
2.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Mundipharma International Limited
2.10.1 Mundipharma International Limited Details
2.10.2 Mundipharma International Limited Major Business
2.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product and Services
2.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Ono Pharmaceutical
2.11.1 Ono Pharmaceutical Details
2.11.2 Ono Pharmaceutical Major Business
2.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
2.11.4 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Takeda Pharmaceutical Company Limited Details
2.12.2 Takeda Pharmaceutical Company Limited Major Business
2.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product and Services
2.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Theravance Biopharma
2.13.1 Theravance Biopharma Details
2.13.2 Theravance Biopharma Major Business
2.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product and Services
2.13.4 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Bausch Health
2.14.1 Bausch Health Details
2.14.2 Bausch Health Major Business
2.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Product and Services
2.14.4 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Cosmo Pharmaceuticals SA
2.15.1 Cosmo Pharmaceuticals SA Details
2.15.2 Cosmo Pharmaceuticals SA Major Business
2.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product and Services
2.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Daewoong Pharmaceutical
2.16.1 Daewoong Pharmaceutical Details
2.16.2 Daewoong Pharmaceutical Major Business
2.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
2.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 C.B. Fleet Company
2.17.1 C.B. Fleet Company Details
2.17.2 C.B. Fleet Company Major Business
2.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product and Services
2.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Sucampo Pharmaceuticals
2.18.1 Sucampo Pharmaceuticals Details
2.18.2 Sucampo Pharmaceuticals Major Business
2.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
2.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 OPIOID INDUCED CONSTIPATION (OIC) DRUG BREAKDOWN DATA BY MANUFACTURER
3.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Opioid Induced Constipation (OIC) Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Opioid Induced Constipation (OIC) Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Opioid Induced Constipation (OIC) Drug Manufacturer Market Share in 2021
3.5 Global Opioid Induced Constipation (OIC) Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Opioid Induced Constipation (OIC) Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Region
4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2028)
4.2 North America Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
4.3 Europe Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
4.4 Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
4.5 South America Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
4.6 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Type (2017-2028)
5.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2028)
5.3 Global Opioid Induced Constipation (OIC) Drug Price by Type (2017-2028)
6 MARKET SEGMENT BY DISTRIBUTION CHANNEL
6.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Distribution Channel (2017-2028)
6.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2028)
6.3 Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
7.1 North America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
7.2 North America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
7.3 North America Opioid Induced Constipation (OIC) Drug Market Size by Country
7.3.1 North America Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
8.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
8.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
8.3 Europe Opioid Induced Constipation (OIC) Drug Market Size by Country
8.3.1 Europe Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL
9.1 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
9.3 Asia-Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region
9.3.1 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL
10.1 South America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
10.2 South America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
10.3 South America Opioid Induced Constipation (OIC) Drug Market Size by Country
10.3.1 South America Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
11.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
11.3 Middle East & Africa Opioid Induced Constipation (OIC) Drug Market Size by Country
11.3.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Opioid Induced Constipation (OIC) Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Opioid Induced Constipation (OIC) Drug
12.3 Opioid Induced Constipation (OIC) Drug Production Process
12.4 Opioid Induced Constipation (OIC) Drug Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Opioid Induced Constipation (OIC) Drug Typical Distributors
13.3 Opioid Induced Constipation (OIC) Drug Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Opioid Induced Constipation (OIC) Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel, (USD Million), 2017 & 2021 & 2028
Table 3. Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Ironwood Pharmaceuticals Major Business
Table 5. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
Table 6. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Daiichi Sankyo Co Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Co Major Business
Table 9. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product and Services
Table 10. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Opioid Induced Constipation (OIC) Drug Product and Services
Table 14. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Progenics Pharmaceuticals Major Business
Table 17. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
Table 18. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Shionogi & Basic Information, Manufacturing Base and Competitors
Table 20. Shionogi & Major Business
Table 21. Shionogi & Opioid Induced Constipation (OIC) Drug Product and Services
Table 22. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Allergan Basic Information, Manufacturing Base and Competitors
Table 24. Allergan Major Business
Table 25. Allergan Opioid Induced Constipation (OIC) Drug Product and Services
Table 26. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Nektar Therapeutics Major Business
Table 29. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product and Services
Table 30. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Purdue Pharma Major Business
Table 33. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product and Services
Table 34. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. S.L.A. Pharma Basic Information, Manufacturing Base and Competitors
Table 36. S.L.A. Pharma Major Business
Table 37. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product and Services
Table 38. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Mundipharma International Limited Basic Information, Manufacturing Base and Competitors
Table 40. Mundipharma International Limited Major Business
Table 41. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product and Services
Table 42. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Ono Pharmaceutical Major Business
Table 45. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
Table 46. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Pharmaceutical Company Limited Major Business
Table 49. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product and Services
Table 50. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table 52. Theravance Biopharma Major Business
Table 53. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product and Services
Table 54. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 56. Bausch Health Major Business
Table 57. Bausch Health Opioid Induced Constipation (OIC) Drug Product and Services
Table 58. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Cosmo Pharmaceuticals SA Basic Information, Manufacturing Base and Competitors
Table 60. Cosmo Pharmaceuticals SA Major Business
Table 61. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product and Services
Table 62. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Daewoong Pharmaceutical Major Business
Table 65. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
Table 66. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. C.B. Fleet Company Basic Information, Manufacturing Base and Competitors
Table 68. C.B. Fleet Company Major Business
Table 69. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product and Services
Table 70. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Sucampo Pharmaceuticals Major Business
Table 73. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
Table 74. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 76. Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 77. Market Position of Manufacturers in Opioid Induced Constipation (OIC) Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 78. Global Opioid Induced Constipation (OIC) Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 79. Head Office and Opioid Induced Constipation (OIC) Drug Production Site of Key Manufacturer
Table 80. Opioid Induced Constipation (OIC) Drug New Entrant and Capacity Expansion Plans
Table 81. Opioid Induced Constipation (OIC) Drug Mergers & Acquisitions in the Past Five Years
Table 82. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022) & (K Units)
Table 83. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2023-2028) & (K Units)
Table 84. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022) & (USD Million)
Table 85. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2023-2028) & (USD Million)
Table 86. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 87. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 88. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2022) & (USD Million)
Table 89. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2023-2028) & (USD Million)
Table 90. Global Opioid Induced Constipation (OIC) Drug Price by Type (2017-2022) & (USD/Unit)
Table 91. Global Opioid Induced Constipation (OIC) Drug Price by Type (2023-2028) & (USD/Unit)
Table 92. Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 93. Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 94. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 95. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 96. Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2017-2022) & (USD/Unit)
Table 97. Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2023-2028) & (USD/Unit)
Table 98. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
Table 99. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
Table 100. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (USD Million)
Table 101. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (USD Million)
Table 102. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 103. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 104. North America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 105. North America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 106. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
Table 107. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
Table 108. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (USD Million)
Table 109. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (USD Million)
Table 110. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 111. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 112. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 113. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 114. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022) & (K Units)
Table 115. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2023-2028) & (K Units)
Table 116. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022) & (USD Million)
Table 117. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2023-2028) & (USD Million)
Table 118. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 119. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 120. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 121. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 122. South America Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
Table 123. South America Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
Table 124. South America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (USD Million)
Table 125. South America Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (USD Million)
Table 126. South America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 127. South America Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 128. South America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 129. South America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 130. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022) & (K Units)
Table 131. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Region (2023-2028) & (K Units)
Table 132. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022) & (USD Million)
Table 133. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Region (2023-2028) & (USD Million)
Table 134. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 135. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 136. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 137. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 138. Opioid Induced Constipation (OIC) Drug Raw Material
Table 139. Key Manufacturers of Opioid Induced Constipation (OIC) Drug Raw Materials
Table 140. Direct Channel Pros & Cons
Table 141. Indirect Channel Pros & Cons
Table 142. Opioid Induced Constipation (OIC) Drug Typical Distributors
Table 143. Opioid Induced Constipation (OIC) Drug Typical Customers
Table 1. Global Opioid Induced Constipation (OIC) Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel, (USD Million), 2017 & 2021 & 2028
Table 3. Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Ironwood Pharmaceuticals Major Business
Table 5. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
Table 6. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Daiichi Sankyo Co Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Co Major Business
Table 9. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product and Services
Table 10. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Opioid Induced Constipation (OIC) Drug Product and Services
Table 14. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Progenics Pharmaceuticals Major Business
Table 17. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
Table 18. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Shionogi & Basic Information, Manufacturing Base and Competitors
Table 20. Shionogi & Major Business
Table 21. Shionogi & Opioid Induced Constipation (OIC) Drug Product and Services
Table 22. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Allergan Basic Information, Manufacturing Base and Competitors
Table 24. Allergan Major Business
Table 25. Allergan Opioid Induced Constipation (OIC) Drug Product and Services
Table 26. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Nektar Therapeutics Major Business
Table 29. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product and Services
Table 30. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Purdue Pharma Major Business
Table 33. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product and Services
Table 34. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. S.L.A. Pharma Basic Information, Manufacturing Base and Competitors
Table 36. S.L.A. Pharma Major Business
Table 37. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product and Services
Table 38. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Mundipharma International Limited Basic Information, Manufacturing Base and Competitors
Table 40. Mundipharma International Limited Major Business
Table 41. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product and Services
Table 42. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Ono Pharmaceutical Major Business
Table 45. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
Table 46. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Pharmaceutical Company Limited Major Business
Table 49. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product and Services
Table 50. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table 52. Theravance Biopharma Major Business
Table 53. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product and Services
Table 54. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 56. Bausch Health Major Business
Table 57. Bausch Health Opioid Induced Constipation (OIC) Drug Product and Services
Table 58. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Cosmo Pharmaceuticals SA Basic Information, Manufacturing Base and Competitors
Table 60. Cosmo Pharmaceuticals SA Major Business
Table 61. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product and Services
Table 62. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Daewoong Pharmaceutical Major Business
Table 65. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
Table 66. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. C.B. Fleet Company Basic Information, Manufacturing Base and Competitors
Table 68. C.B. Fleet Company Major Business
Table 69. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product and Services
Table 70. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Sucampo Pharmaceuticals Major Business
Table 73. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
Table 74. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 76. Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 77. Market Position of Manufacturers in Opioid Induced Constipation (OIC) Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 78. Global Opioid Induced Constipation (OIC) Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 79. Head Office and Opioid Induced Constipation (OIC) Drug Production Site of Key Manufacturer
Table 80. Opioid Induced Constipation (OIC) Drug New Entrant and Capacity Expansion Plans
Table 81. Opioid Induced Constipation (OIC) Drug Mergers & Acquisitions in the Past Five Years
Table 82. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022) & (K Units)
Table 83. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2023-2028) & (K Units)
Table 84. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022) & (USD Million)
Table 85. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2023-2028) & (USD Million)
Table 86. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 87. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 88. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2022) & (USD Million)
Table 89. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2023-2028) & (USD Million)
Table 90. Global Opioid Induced Constipation (OIC) Drug Price by Type (2017-2022) & (USD/Unit)
Table 91. Global Opioid Induced Constipation (OIC) Drug Price by Type (2023-2028) & (USD/Unit)
Table 92. Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 93. Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 94. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 95. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 96. Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2017-2022) & (USD/Unit)
Table 97. Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2023-2028) & (USD/Unit)
Table 98. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
Table 99. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
Table 100. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (USD Million)
Table 101. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (USD Million)
Table 102. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 103. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 104. North America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 105. North America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 106. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
Table 107. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
Table 108. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (USD Million)
Table 109. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (USD Million)
Table 110. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 111. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 112. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 113. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 114. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022) & (K Units)
Table 115. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2023-2028) & (K Units)
Table 116. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022) & (USD Million)
Table 117. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2023-2028) & (USD Million)
Table 118. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 119. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 120. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 121. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 122. South America Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
Table 123. South America Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
Table 124. South America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (USD Million)
Table 125. South America Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (USD Million)
Table 126. South America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 127. South America Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 128. South America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 129. South America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 130. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022) & (K Units)
Table 131. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Region (2023-2028) & (K Units)
Table 132. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022) & (USD Million)
Table 133. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Region (2023-2028) & (USD Million)
Table 134. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
Table 135. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
Table 136. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 137. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 138. Opioid Induced Constipation (OIC) Drug Raw Material
Table 139. Key Manufacturers of Opioid Induced Constipation (OIC) Drug Raw Materials
Table 140. Direct Channel Pros & Cons
Table 141. Indirect Channel Pros & Cons
Table 142. Opioid Induced Constipation (OIC) Drug Typical Distributors
Table 143. Opioid Induced Constipation (OIC) Drug Typical Customers
LIST OF FIGURES
Figure 1. Opioid Induced Constipation (OIC) Drug Picture
Figure 2. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type in 2021
Figure 3. Lubiprostone
Figure 4. Methyl Naltrexone Bromide
Figure 5. Naldemedine
Figure 6. Alvimopan
Figure 7. Other
Figure 8. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel in 2021
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Opioid Induced Constipation (OIC) Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Opioid Induced Constipation (OIC) Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Opioid Induced Constipation (OIC) Drug Sales (2017-2028) & (K Units)
Figure 15. Global Opioid Induced Constipation (OIC) Drug Price (2017-2028) & (USD/Unit)
Figure 16. Global Opioid Induced Constipation (OIC) Drug Production Capacity (2017-2028) & (K Units)
Figure 17. Global Opioid Induced Constipation (OIC) Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Opioid Induced Constipation (OIC) Drug Market Drivers
Figure 19. Opioid Induced Constipation (OIC) Drug Market Restraints
Figure 20. Opioid Induced Constipation (OIC) Drug Market Trends
Figure 21. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturer in 2021
Figure 22. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturer in 2021
Figure 23. Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Opioid Induced Constipation (OIC) Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Opioid Induced Constipation (OIC) Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2028)
Figure 27. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2017-2028)
Figure 28. North America Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 29. Europe Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 31. South America Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 34. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global Opioid Induced Constipation (OIC) Drug Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 37. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2028)
Figure 38. Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2017-2028) & (USD/Unit)
Figure 39. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 40. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 41. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2017-2028)
Figure 42. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2017-2028)
Figure 43. United States Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 48. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2017-2028)
Figure 49. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2017-2028)
Figure 50. Germany Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 57. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2017-2028)
Figure 59. China Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 66. South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 67. South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2017-2028)
Figure 68. South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 73. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug in 2021
Figure 80. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
Figure 81. Opioid Induced Constipation (OIC) Drug Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Opioid Induced Constipation (OIC) Drug Picture
Figure 2. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type in 2021
Figure 3. Lubiprostone
Figure 4. Methyl Naltrexone Bromide
Figure 5. Naldemedine
Figure 6. Alvimopan
Figure 7. Other
Figure 8. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel in 2021
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Opioid Induced Constipation (OIC) Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Opioid Induced Constipation (OIC) Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Opioid Induced Constipation (OIC) Drug Sales (2017-2028) & (K Units)
Figure 15. Global Opioid Induced Constipation (OIC) Drug Price (2017-2028) & (USD/Unit)
Figure 16. Global Opioid Induced Constipation (OIC) Drug Production Capacity (2017-2028) & (K Units)
Figure 17. Global Opioid Induced Constipation (OIC) Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Opioid Induced Constipation (OIC) Drug Market Drivers
Figure 19. Opioid Induced Constipation (OIC) Drug Market Restraints
Figure 20. Opioid Induced Constipation (OIC) Drug Market Trends
Figure 21. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturer in 2021
Figure 22. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturer in 2021
Figure 23. Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Opioid Induced Constipation (OIC) Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Opioid Induced Constipation (OIC) Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2028)
Figure 27. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2017-2028)
Figure 28. North America Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 29. Europe Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 31. South America Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (USD Million)
Figure 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 34. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global Opioid Induced Constipation (OIC) Drug Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 37. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2028)
Figure 38. Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2017-2028) & (USD/Unit)
Figure 39. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 40. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 41. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2017-2028)
Figure 42. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2017-2028)
Figure 43. United States Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 48. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2017-2028)
Figure 49. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2017-2028)
Figure 50. Germany Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 57. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2017-2028)
Figure 59. China Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 66. South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 67. South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2017-2028)
Figure 68. South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 73. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Opioid Induced Constipation (OIC) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug in 2021
Figure 80. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
Figure 81. Opioid Induced Constipation (OIC) Drug Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
